Linezolid-associated adverse events and outcomes in the treatment of multidrug/rifampicin-resistant tuberculosis: A systematic review and meta-analysis of randomized controlled trials

Mita Restinia; Jheng-Yan Wu; Fajri Gafar; Wen-Hsuan Hou; Chung-Yi Li

doi:10.1016/j.jiph.2026.103212

Q1 2026

Linezolid-associated adverse events and outcomes in the treatment of multidrug/rifampicin-resistant tuberculosis: A systematic review and meta-analysis of randomized controlled trials

Mita Restinia · Jheng-Yan Wu · Fajri Gafar · Wen-Hsuan Hou · Chung-Yi Li

10.1016/j.jiph.2026.103212 389 Views 0 Citations

Citations

389

Views

Abstract not available for this publication.

Cite this Article (APA)

Mita, R., Jheng-Yan, W., Fajri, G., Wen-Hsuan, H., Chung-Yi, L. (2026). Linezolid-associated adverse events and outcomes in the treatment of multidrug/rifampicin-resistant tuberculosis: A systematic review and meta-analysis of randomized controlled trials. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2026.103212